Should we shift the paradigm of preclinical models for ARDS therapies?

William Bain¹, Gustavo Matute-Bello^{2

3}

Affiliations

¹ Department of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
² Center for Lung Biology, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA matuteb@uw.edu.
³ Veterans Administration Puget Sound Healthcare System, Seattle, WA, United States.

Editorial

William Bain et al. Thorax. 2019 Dec.

. 2019 Dec;74(12):1109-1110.

doi: 10.1136/thoraxjnl-2019-213729. Epub 2019 Oct 17.

William Bain¹, Gustavo Matute-Bello^{2

3}

¹ Department of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
² Center for Lung Biology, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA matuteb@uw.edu.
³ Veterans Administration Puget Sound Healthcare System, Seattle, WA, United States.

No abstract available

Conflict of interest statement

Competing interests: None declared.

Ventilation following established ARDS: a preclinical model framework to improve predictive power.
Oakley C, Koh M, Baldi R, Soni S, O'Dea K, Takata M, Wilson M. Oakley C, et al. Thorax. 2019 Dec;74(12):1120-1129. doi: 10.1136/thoraxjnl-2019-213460. Epub 2019 Jul 5. Thorax. 2019. PMID: 31278170 Free PMC article.